Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Nominations
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
      Research & Development

      Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

      July 30, 2025
      Research & Development

      $20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

      July 11, 2025
      Research & Development

      Scientists Identify New Target to Prevent Cancer from Spreading to Bones

      May 22, 2025
  • Clinical
    • Clinical

      Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101

      October 17, 2025
      Clinical

      Moderna Reveals Promising Melanoma Data Behind Decision to Proceed With Cancer Candidate

      October 15, 2025
      Clinical

      Amgen reports Vesalius-CV topline showing Repatha reduces MACE in primary-prevention patients

      October 3, 2025
      Clinical

      Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

      September 30, 2025
  • Commercial
    • AllBrand & Marketing
      Commercial

      Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months

      October 17, 2025
      Commercial

      AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases

      October 15, 2025
      Commercial

      Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space

      October 15, 2025
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      Reg impact assessment next in GenAI’s sights, experts claim

      June 26, 2025
      Insights

      The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

      December 1, 2024
      Insights

      Improving life science R&D outcomes with AI

      November 8, 2024
      Insights

      The medical device sector’s surging regulatory burden: how are suppliers coping?

      October 12, 2024
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Nominations
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Rybelsus

Tag: Rybelsus

FDA

FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2...

Editotial Team - October 22, 2025 0

Editor Picks

Merck partner NGM biopharmaceuticals’ eye drug unsuccessful in Phase 2 clinical trials

October 31, 2022

Life Sciences Voice Top Five Newsletter

September 1, 2025

Promising phase 3 results propel Bayer’s menopause drug towards approval

March 22, 2024

Must Read

FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients

October 22, 2025

FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis

October 21, 2025

Merck expands once more as part of a planned $70 billion US investment

October 21, 2025

Hot Topics

  • Clinical356
  • Commercial345
  • Regulatory282
  • Research & Development101
  • Manufacturing71
  • Newsletter59
  • Technology40
  • News31
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Nominations
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial